Kathleen Raven

Kathleen Raven reports on cutting-edge solid tumor cancer drug developments and clinical trials for BioPharm Insight, owned by The Financial Times Group, in New York City. She’s previously written for Reuters Health, Scientific American, MATTER, Nature Medicine and other U.S. publications. She has been a recipient of the following short-term reporting fellowships: National Academies Keck Futures Initiative, Goethe Institute, Fulbright Berlin Capital and Falling Walls. She has two master’s degrees from the University of Georgia in Ecology and Health & Medical Journalism.

Posts:

• Von Frau zu Frau: Wissenschaft und Familie, 03 Jul 2014
• Research For the Dogs – Young Scientist profiles, 02 Jul 2014
• Women to Women: Science and Family, 01 Jul 2014
• An Interview With A Young Researcher: Bettina Keller, 12 Jul 2013
• Ada Yonath and the Female Question, 11 Jul 2013
• Energy storage, rare metals and the next ice age, 05 Jul 2013
• Imaging the near invisible with TEM: a master class, 03 Jul 2013
• ‘Chemistry and physics: one needs the other’, 01 Jul 2013
• Cataloging the impact of Lindau meetings, 26 Jun 2013
• ‘Videos with a personality, flow and message’, 21 Jun 2013